Overall rank by patents
#32,592
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Nichirei Biosciences Inc.
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, active 2017–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
8
Total patents granted
5
CPC technology areas
9.9
Avg claims per patent
-40%
5-year filing velocity
The verdict
Nichirei holds 8 US patents across 5 technology areas, rank #32,592 of 50,000 tracked assignees.
- #32,592
- of 50,000 US assignees by volume
- Top 89%
- by Innovation Score (23.1/100)
- 9.9
- avg claims per patent
- -40%
- filing velocity, last 5 yrs
Portfolio overview
Nichirei Biosciences Inc. has been granted 8 US utility patents between 2017 and 2023, placing Nichirei Biosciences Inc. at rank #32,592 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.9 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Nichirei Biosciences Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Nichirei sits between Nexkey, Inc. (8 patents, rank #32,588) and Nimbix, Inc. (8 patents, rank #32,596) - the closest US assignees by grant volume. The composite Innovation Score of 23.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 5 in the 2015–2019 window, a -40% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Nichirei Biosciences Inc.'s 9.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nichirei Biosciences Inc. against peers pursuing similar technology classes.
Who files at Nichirei's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nexkey
NEXKEY, INC.
8 patents
- Nfinity IP
NFINITY IP, LLC
8 patents
- Nflection Therape…
NFLECTION THERAPEUTICS, INC.
8 patents
- NHS
NHS, Inc.
8 patents
- NIDA TECH Sweden…
NIDA TECH SWEDEN AB
8 patents
- Nidec Techno Motor
NIDEC TECHNO MOTOR CORPORATION
8 patents
- Nikon Engineering
NIKON ENGINEERING CO., LTD.
8 patents
- Nimbix
NIMBIX, INC.
8 patents
- Nichirei Bioscien… ◀
NICHIREI BIOSCIENCES INC.
8 patents
What this shows Nichirei holds 8 patents at rank #32,592, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Nichirei
By rank, the assignees closest to #32,592 in granted patent volume.
- Nexkey, Inc. #32,588 · 8 patents
- Nfinity IP, Llc #32,589 · 8 patents
- Nflection Therapeutics, Inc. #32,590 · 8 patents
- NHS, Inc. #32,591 · 8 patents
- NIDA TECH Sweden AB #32,593 · 8 patents
- Nidec Techno Motor Corporation #32,594 · 8 patents
- Nikon Engineering Co., Ltd. #32,595 · 8 patents
- Nimbix, Inc. #32,596 · 8 patents
Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)
Other assignees with the most granted patents in Nichirei's primary technology class.
- The Regents Of The University Of California 1,153 in class
- Shimadzu Corporation 1,111 in class
- Saudi Arabian OIL Company 837 in class
- Halliburton Energy Services, Inc. 816 in class
- The Boeing Company 701 in class
- General Electric Company 634 in class
- Kla-tencor Corporation 583 in class
- Massachusetts Institute Of Technology 530 in class
Nichirei's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
23 Top 89% higher than 11% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 25.0% |
| 2018 | 1 | 12.5% |
| 2019 | 2 | 25.0% |
| 2020 | 1 | 12.5% |
| 2021 | 1 | 12.5% |
| 2023 | 1 | 12.5% |
Which technologies does Nichirei Biosciences Inc. patent most?
Top 5 of 5 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Nichirei Biosciences Inc. hold?
Nichirei Biosciences Inc. holds 8 US granted patents filed between 2017 and 2023, spanning 5 technology areas.
What is Nichirei Biosciences Inc.'s Innovation Score?
Nichirei Biosciences Inc. has an Innovation Score of 23.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Nichirei Biosciences Inc. focus on?
Nichirei Biosciences Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 7 patents. The company has filed patents in 5 CPC subclasses total.
Is Nichirei Biosciences Inc.'s patent filing rate increasing or decreasing?
Nichirei Biosciences Inc.'s recent filing velocity is -40% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Nichirei Biosciences Inc.'s patents?
Nichirei Biosciences Inc.'s patents average 9.9 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Nichirei Biosciences Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Nichirei's 8 grants land it in the top 89% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Nichirei ranks #32,592 of 50,000. Top 50 holders
- Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.